"http://www.patentstorm.us/patents/5731357/description.html
CONCLUSION. The administration of the preparation "Ropren" enables to achieve clinical remission for the patients with disseminated sclerosis."
This patent appears to have expired in 2006, through failure to pay the maintenance fee, according to this link:
http://www.uspto.gov/go/og/2006/week21/patexpi.htm
- Forums
- ASX - By Stock
- SLA
- how big do u recon this share can be
how big do u recon this share can be, page-28
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online